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Abstract 
Background: Malignant melanomas of the head and neck are usually considered as a unique entity 
in comparison to other body sites. However, no characterization of neck melanoma has been 
performed so far, despite the clear anatomic and histological differences. Aim: We investigated 
clinical, demographic, histological and dermoscopic differences between face, scalp and neck 
melanoma. Materials and methods: A retrospective analysis of medical and histologic records from 
116 melanomas of the head and neck area collected between January 2003 and January 2008 was 
performed. Body site, gender, age, number of lesions, age at first melanoma diagnosis, size, Clark 
level, association with nevi, presence or absence of mitoses and/or ulceration, presence of 
synchronous and/or metachronous melanoma were recorded. Moreover, digital dermoscopy images 
of 92 melanomas of the head and neck area were analyzed for main dermoscopic patterns and lesion 
diameter. Results: Significant differences in Breslow thickness, ex-naevo origin and tumor size 
among neck and face-scalp melanomas were observed. Neck MM patients were younger than those 
with MM of face and scalp. In contrast to scalp and face, no patient died from neck melanoma. 
Dermoscopic patterns were similar to those of trunk-limbs MM, and no lesion showed a lentigo 
maligna pattern which was observed in most lesions of the face. Conclusion: Melanomas of the neck 
must be distinguished from face and scalp melanomas because of younger age, different dermoscopic 
patterns and ex-naevo origin and better prognosis. These data should be taken into account both from 
an epidemiological and clinical point of view. 
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Introduction 
Head and neck Malignant Melanomas (MMs) are usually considered a unique entity with common 
clinico-pathological features with respect to MMs of other body sites. Several studies analyzed MMs 
of this anatomic macro-region, including the scalp, the face, and the neck in comparison with other 
body sites (1,2). The main reason for this melanoma categorization is that head and neck are more 
heavily exposed to UV radiation than any other body site and that the surgical approach is customarily 
performed by head and neck surgeons, who treat these lesions without differentiating the specific 
anatomic locations. 
Some studies highlighted the differences between MMs of the scalp and of face/neck (1) showing a 
5 year overall survival rate of 81.8% for face and neck and 66.7% for the scalp, as well as specific 
dermoscopic patterns for scalp tumors (3). However, to the best of our knowledge, no specific 
evidence regarding the neck versus the facial localization is reported in literature. It is recognized that 
between neck and face skin there are clearly evident anatomic and cyto-architectural differences, 
concerning the peculiar vascular and lymphatic drainage patterns, the dermal-epidermal junction, the 
dermis and hair follicles size and density (4). Less data are available for the clinico-pathologic, 
dermoscopic, and prognostic features of melanocytic lesions differentiating these two contiguous but 
different anatomic regions. 
Lentigo maligna melanoma (LMM), for which delayed diagnosis is common due to its inconspicuous 
presentation at an early stage, represents the most common type of melanoma on the face. Clinically, 
the well-known “ABCD rule” cannot be applied to facial lesions (5). From a dermoscopic point of 
view it is known that this efficient non-invasive technique increases the rate of correct melanoma 
diagnosis by using criteria involving different patterns and/or structures for melanocytic lesions (6), 
which are site specific for three distinct anatomic locations: head (including scalp and face), 
trunk/limbs and palmo-plantar region (7). MMs of the face do not show the classical dermoscopic 
findings typically observed elsewhere on the skin (8). Stolz et al. described four steps of LMM 
invasion of the hair follicles observed by dermoscopy (9). In this study we analyzed the clinico-
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pathologic, dermoscopic, and prognostic differences between head, scalp and neck malignant 
melanoma. 
Materials and methods 
This study was carried out at the Department of Dermatology of the University of Modena and Reggio 
Emilia based on a retrospective analysis of 116 MMs of the head and neck area recorded between 
January 2003 and January 2008. The study design, criteria for inclusion and therapeutic protocol were 
approved by the ethical committee of the same University. Patients’ clinical data, such as anatomic 
distribution, gender, age, number of lesions, age at first melanoma diagnosis, size, Clark level, 
association with nevi, presence or absence of mitoses and/or ulceration, presence of synchronous 
and/or metachronous melanoma were tabulated via medical records. Patients were classified in 
according with the American Joint Committee on Cancer (AJCC) staging system basing on the 
characteristics of the first lesion (10,11). 
The inclusion criteria for head and neck melanoma were: 
• patients of both genders older than 18 years, Caucasian race, with at least one melanoma 
in the head and neck area clinically diagnosed and histologically proven; 
• availability of medical records with complete demographic, clinical and radiological 
procedures performed at diagnosis and repeated every 12 months during follow-up; 
• patients with at least three years of follow-up. 
Exclusion criteria encompassed: 
• patients with pigmented lesions localized on mucosal surfaces (oral mucosa, nasal mucosa); 
• patients with recurrences, in transit, and distant metastases or unknown primary melanomas; 
• patients with incomplete histopathological data. 
Dermoscopy 
Dermoscopic images were recorded by means of a digital videomicroscope (FotoFinder, TeachScreen 
software GmbH, Bad Birnbach, Germany), using a 20- and a 50-fold magnification. The instrument 
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and the calibration method have already been described elsewhere (12). Images were examined by 3 
expert dermoscopists for classification into main dermoscopic patterns (12-17). The lesion was 
definitely attributed to a group when at least two observers agreed. 
Atypical pseudonetwork, the lentigo maligna main pattern, was defined by Schiffner et al. for the 
diagnosis of facial melanoma, as the presence of asymmetric pigmented hair follicular openings, 
rhomboidal structures, annular-granular structures, black dots within the hair follicle or destruction 
of the hair follicles (Figure 1 and 2) (17). The reticular-globular pattern included lesions with the 
contemporary presence of network and globules, whereas when structureless areas coexisted with 
globules, we adopted the term homogeneous-globular (Figure 3a). In the group with island, we 
comprised lesions containing a well circumscribed lesion area, showing a uniform dermoscopic 
pattern, differing from the one present in the rest of the lesion (14). Amelanotic pattern included 
lesions without recognizable pigmented structures (15). The flat-nodular pattern (Figure 3b) was 
recognized in lesions showing a nodular component and some areas at the periphery where an atypical 
pseudonetwork was identifiable (15). Finally, an aspecific pattern was attributed to MMs not 
categorized in other subgroups. Differences between MMs of face, scalp and neck were studied 
employing demographic and dermoscopic data. 
Data analysis 
A statistical analysis was carried out using the Statistical Package for the Social Science (SPSS), 
Version 9.02 for Windows®. Data were expressed as mean and standard deviation (SD). Differences 
between in the different groups were calculated by Kruskal-Wallis test. P-values below 0.05 for all 
tests were considered statistically significant. 
Results 
During the study period January 2003 - January 2008, 1256 patients were diagnosed with melanoma 
in different body areas at the Department of Dermatology of the University of Modena. A subgroup 
of 116 patients were diagnosed with MMs in the head and neck area, comprising 93 patients with 
melanoma of the face, 13 patients with melanoma of the scalp and 10 patients with melanoma of the 
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neck. As regards face involvement, the most affected site was the cheek (28.4%) followed by the 
zygomatic area (13.7%) and the forehead (7.8%), while 13 (11.2%) MMs were localized on the scalp 
and 10 (8.6%) in the neck area. 
Demographic data for each patient subgroup are described in Table 1. The estimated overall 10-year 
survival rate (according to the method of Kaplan-Meier) was calculated for the three different 
anatomical areas (Figure 4). 
Patients affected by MMs of the neck area were significantly younger, with a mean age at diagnosis 
of 62.6 ± 11.8 years (CI 54.2-71.03). Instead, patients with MMs localized on the face were 
significantly older, with a mean age at diagnosis of 73.9 ± 11.5 years (CI 71.6-76.2). 
Thickness and diameter of lesions were significantly different between scalp MMs and lesions of the 
face and neck. Lesions with a Breslow’s thickness >4 were more frequently present among scalp 
MMs compared to face and neck MMs. The percentage of lesion with mitoses was higher on the face, 
while the mean number of mitoses was higher for scalp lesions. 
An ex-naevo origin was observable in 13.92% of lesions on the face, in 14.29% of scalp lesions, and 
in 50% of neck lesions. As concerning the staging, patients were assigned to the AJCC classification 
on the basis of characteristics of the first melanoma (Table 2). Of 13 MMs located on the scalp, 5 
(38.5%) were stage IIB compared to face (5.38%) and neck (0%) MMs. 
Positive sentinel lymph nodes were more frequently present in 4 (30.8%) patients with melanoma 
of the scalp. Melanoma was a significant cause of death among patients with a scalp localization. 
Multiple primary MMs were diagnosed only in 6 patients with melanoma localized in the face area: 
in 4 patients they were synchronous while in 2 patient metachronous. 
Dermoscopic images were available for face MMs in 71 cases, for scalp MMs in 11 cases, and for 
neck ones in 10 subjects. Table 3 illustrates the dermoscopic, clinical and histological aspects of 82 
face/scalp MMs, whose dermoscopic images were available, according to thickness. The following 
main dermoscopic patterns were recognized in face and scalp MMs: atypical pseudonetwork (67 
cases), flat-nodular (9 cases), amelanotic (2 cases), reticular-globular (one case), homogeneous-
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globular (one case), island (one case) and aspecific (one case). When subdividing face and scalp MMs 
according to thickness range, diameter did not significantly vary according in the different subgroups, 
whereas main dermoscopic patterns were differently distributed. The lentigo maligna (atypical 
pseudonetwork) pattern was observable in most MMs thinner than 2 mm. Among MMs in situ, one 
lesion was amelanotic and another one showed the contemporary presence of network and globules; 
thin invasive MMs (<1 mm) showed an amelanotic aspect in one case, the presence of structureless 
pigmentation and globules in one case and an island pattern in one case. All lesions 1-2 mm thick 
showed the lentigo maligna pattern, whereas thicker ones presented a flat-nodular pattern in 9 cases 
and an aspecific one in one case. 
Neck MMs displayed reticular (2 cases), reticular-globular (2 cases), homogeneous (2 cases), 
multicomponent (1 case), globular-structureless (1 case), dermoscopic island (1 cases) and aspecific 
(1 case) main patterns. No neck melanoma showed a lentigo maligna pattern. 
Discussion 
The analysis of the clinic and pathological differences between MMs of the face and of the neck 
revealed that the latter localization is quite uncommon and associated to better prognosis, when 
compared to the face, although the effective reasons of such evidence are still unclear. Our data 
confirm that neck and scalp MMs predominate in men (2); the reason of this observation may be that 
men are often bald-headed and tend to have shorter hair than women with a relative more intensive 
neck exposure to UV radiation. In contrast to what previously described (18) patients with neck 
melanoma tend to be younger than those with MMs arising on the face/scalp, independent of the 
histologic subtype. 
It is already well known that scalp tumors have the worst prognosis compared to their counterparts in 
other localizations (1-3). However, in contrast to scalp melanoma, the prognosis of neck melanoma 
may be influenced by different factors which can have an critical impact on the prognosis, i.e. the 
easier detection on glabrous skin and the different lymphatic and vascular drainage patterns involved 
in the growth and spreading patterns. In particular, previous studies demonstrate that cutaneous 
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lymphatic drainage pathways display anatomic variations among patients, especially in the head and 
neck area (19-21). It is important to note that more than 40% of MMs of the anterior and posterior 
lower neck show discordancy from clinically predicted lymphatic drainage showing multiple, varied 
and asymmetric lymphatic drainage patterns possibly associated to higher metastatic potential (22). 
However, our data do not confirm literature observations regarding the worse prognosis of neck 
melanoma. 
While sun exposure may plays an equivalent role in the development of face and neck MMs, 
differences in early detection and prognosis could be related to peculiar anatomic features of neck 
skin, which is similar to other body sites’, but very different from facial skin. In fact, the latter is 
distinguished by a flat dermal-epidermal junction and hair follicles of higher size and density (4) 
possibly responsible for the higher density of vascular and lymphatic structures, as well as for a higher 
mitotic activity in the basal layer, that might anticipate tumor invasion and the transition from 
horizontal to vertical growth. 
Dermoscopic patterns vary according to skin site. For face and acral lesions peculiar dermoscopic 
patterns have been identified, showing striking differences with respect to those employed for 
diagnostic analysis of lesions located on trunk and limbs. These differences rely on the anatomic 
characteristics of facial skin presenting a higher size and density of pilosebaceous units (4). Schiffner 
et al. first described the evolving lentigo maligna pattern in facial melanoma underlying its peculiar 
mode of growth (17). However, to the best of our knowledge other peculiar dermoscopic patterns of 
face and scalp MMs, especially referring to their vertical growth phase, have not been described so 
far. In this study we showed that most facial MMs maintain the lentigo maligna pattern until they 
reach the thickness of 2 mm. Above this threshold, a so called flat-nodular pattern is observable, 
characterized by a flat component often presenting a rhomboidal structure, and a vertical component 
showing structureless pigmentation. In most of these lesions the characteristic melanoma features 
observable in MMs at other skin sites are not identifiable, and this may correspond to a peculiar 
biological behavior of MMs of face and scalp, also supported by a higher rate of lesions starting de-
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novo and not related to a malignant transformation of a nevus. On the contrary, neck MMs present a 
variety of dermoscopic patterns such as those found in malignant melanocytic lesions located at other 
skin sites, and accordingly, their age of onset and ex-naevo origin reflects the one of non-head MMs. 
Scientific literature usually reports head and neck MMs as an unique entity; this creates a 
methodological and clinical bias since the two locations might give rise to tumors with different 
biological behavior. As a consequence, epidemiologic data obtained from medical records including 
both melanoma sites may be prejudiced, and patients are followed with the same treatment and 
follow-up protocols. We suggest therefore that MMs of the face should be equalized to its scalp 
counterpart for diagnosis and surveillance, and that neck MMs should be assimilated to those of trunk-
limbs ones. In particular, the very poor prognosis of scalp melanoma as well as face tumors must be 
taken into account in order to better differentiate detection processes, surgical management and 
follow-up strategies. 
Conclusions 
The main evidences of this single-institution study can be summarized as following: 
1) Although scientific literature has stressed the differences between MMs of the scalp and other 
head-neck locations, the characterization of neck melanoma is still not clear. We conclude that 
melanoma of the neck represent a distinct entity from the clinic-pathological, dermoscopic and 
prognostic features and should therefore be separated by its facial counterpart in the clinical 
assessment and management. 
2) The anatomical peculiarities of the cutaneous districts are reflected in the related dermoscopic 
patterns. As a consequence, the skin of the neck does not present the same dermoscopic features 
as the face and scalp but rather those of the trunk. 
3) The very poor prognosis of scalp melanoma as well as face tumors must be taken into account in 
order to better differentiate detection processes, surgical management and follow-up strategies. 
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Table 1. Clinical, histological and dermoscopic characteristics of scalp, face and neck melanomas 
 Face Scalp Neck Face vs Scalp Face vs Neck  Scalp vs Neck 
P-value 
(Kruskal-
Wallis test) 
Patients (%) 93 (80.2%) 13 (11.2%) 10 (8.6%) <0.001 <0.001 <0.001 <0.0001 
Female 39 (41.9%) 4 (30.8%) 2 (20%) >0.05 >0.05 >0.05 0.3 
Male 54 (58.1%) 9 (69.2%) 8 (80%) >0.05 >0.05 >0.05 0.3 
Age 
73.9 ± 11.5 
(CI 71.6-76.2) 
68.5 ± 16.9 
(CI 58.2-78.7) 
62.6 ± 11.8 
(CI 54.2-71.03) 
>0.05 <0.05 >0.05 0.02 
Thickness 
(mm ± SD) 
0.6 ± 1.4 
(CI 0.3-0.9) 
3.9 ± 4.5 
(CI 1.2-6.6) 
0.6 ± 0.9 
(CI 0.02-1.2) 
>0.05 >0.05 >0.05 0.04 
Diameter 
(mm ± SD) 
15.3 ± 8 21.3 ± 13.8 14.6 ± 7.4 
>0.05 >0.05 >0.05 0.43 
(CI 13.6-16.9) (CI 12.9-29.7) (CI 9.3-19.9) 
Lesions with 
mitoses 
13 (11.2%) 7 (6.01%) 2 (1.7%) <0.01 >0.05 >0.05 <0.003 
Mean number of 
mitoses 
0.6 ± 3.4 
(CI 0.03-1.4) 
6.6 ± 13.9 
(CI 1.8-15) 
1 ± 2.8 
(CI 1-3) 
 
Ex-naevo/de-novo 13.92% 14.29% 50% >0.05 <0.01 >0.05 0.007 
Clark level 
I 51 (54.8%) 0 (0%) 3 (30%) <0.001 >0.05 >0.05 0.0006 
II 29 (31.2%) 2 (15.4%) 4 (40%) >0.05 >0.05 >0.05 0.4 
III 7 (7.5%) 1 (7.7%) 2 (20%) >0.05 >0.05 >0.05 0.4 
IV 6 (6.5%) 1 (7.7%) 1 (10%) >0.05 >0.05 >0.05 0.3 
15  
V 4 (4.3%) 5 (38.5%) 0 (0%) <0.001 >0.05 <0.01 <0.0001 
Breslow’s thickness 
MIS 51 (54.8%) 3 (23.1%) 3 (30%) >0.05 >0.05 >0.05 0.04 
≤1.00 33 (35.5%) 3 (23.1%) 6 (60%) >0.05 >0.05 >0.05 0.2 
1.01-2.00 6 (6.5%) 0 (0%) 0 (0%) >0.05 >0.05 >0.05 0.5 
2.01-4.00 2 (2.2%) 0 (0%) 1 (10%) >0.05 >0.05 >0.05 0.3 
>4.00 5 (5.3%) 6 (46.2%) 0 (0%) <0.001 >0.05 <0.001 <0.0001 
Sentinel lymph nodes 
Positive 1 (1.1%) 2 (15.4%) 1 (10%) <0.05 >0.05 >0.05 0.02 
Negative 5 (5.3%) 2 (15.4%) 0 (0%) >0.05 >0.05 >0.05 0.3 
Not done 88 (94.6%) 9 (69.2%) 9 (10%) <0.01 >0.05 >0.05 0.009 
Multiple primary melanomas 
Synchronous 0 (0%) 4 (30.8%) 0 (0%) <0.001 >0.05 <0.001 0.0001 
Metachronous 0 (0%) 2 (15.4%) 0 (0%) <0.001 >0.05 <0.05 0.0003 
5-years overall 
survival 
89 (95.7%) 9 (64.3%) 10 (100%) <0.05 <0.001 <0.001 <0.0001 
 
16  
Table 2. Clinical staging of all melanoma lesions 
Stage at initial 
diagnosis 
Face Scalp Neck Face vs Scalp Face vs Neck Scalp vs Neck 
P-value (Kruskal-
Wallis test) 
0 49 (42.2%) 4 (3.4%) 2 (1.7%) >0.05 >0.05 >0.05 0.06 
IA 27 (23.3%) 3 (2.6%) 7 (6.03%) >0.05 >0.05 >0.05 0.1 
IB 9 (7.8%) 0 (0%) 0 (0%) >0.05 >0.05 >0.05 0.3 
IIA 2 (1.7%) 0 (0%) 0 (0%) >0.05 >0.05 >0.05 0.8 
IIB 5 (4.3%) 5 (4.3%) 0 (0%) <0.001 >0.05 <0.01 0.0002 
IIC 0 (0%) 0 (0%) 0 (0%) 0 0 0 0 
IIIA 1 (0.09%) 1 (0.09%) 1 (0.09%) >0.05 >0.05 >0.05 0.11 
IIIB 0 (0%) 0 (0%) 0 (0%) 0 0 0 0 
IIIC 0 (0%) 0 (0%) 0 (0%) 0 0 0 0 
IV 0 (0%) 0 (0%) 0 (0%) 0 0 0 0 
Unknown 0 (0%) 0 (0%) 0 (0%) 0 0 0 0 
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Figure 1. Lentigo maligna progression as assessed by dermoscopy (FotoFinder, 20-fold 
magnification): a) light brown pigmentation around follicular openings; b) dark brown and grey- 
blue rhomboidal structures around hair follicles; c) besides rhomboidal structures, homogeneous 
grey-blue pigmentation occluding hair follicle openings can be seen along with a nodular 
component. 
 
 
 
 
Figure 2. Lentigo maligna progression as assessed by high magnification dermoscopy (FotoFinder, 
50-fold magnification): a) follicular openings appear as target structures with a perifollicular halo 
surrounding a small dot in the centre; light brown and dotted rhomboidal structures around hair 
follicles are also visible; b) dark brown and grey-blue rhomboidal structures centered by gray-blue 
hair follicles and homogeneous grey-blue pigmentation. 
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Figure 3. Melanoma of the face/scalp: a) the homogeneous-globular pattern in a melanoma on the 
cheek; b) the flat-nodular pattern in a melanoma on the scalp. 
 
 
 
 
Figure 4. Kaplan-Meier 10-year overall survival estimated for different anatomical areas: face, 
scalp and neck. 
